New hope to tame dangerous side effects of powerful cancer drugs
NCT ID NCT04375228
Summary
This study is testing two drugs, rituximab or tocilizumab, to help people with advanced cancer who develop severe, long-lasting side effects from their immunotherapy treatment. These side effects often require patients to take high doses of steroids, which can cause serious health problems. The main goal is to see if these new drugs can help patients safely stop taking steroids while still controlling the side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
Johns Hopkins
Baltimore, Maryland, 21224, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10022, United States
Conditions
Explore the condition pages connected to this study.